Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
EyePoint Pharmaceuticals, Inc. (EYPT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
2 Feb 2024
Jones David Scott
SVP & Chief Commercial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
37,962
-0%
209
$28.49
$5,954.41
SELL
26 Jan 2024
Jones David Scott
SVP & Chief Commercial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
47,566
-35%
26,017
$25.38
$660,370.50
SELL
26 Jan 2024
Paggiarino Dario A.
Chief Medical Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
85,779
-36%
49,325
$25.66
$1,265,539.00
SELL
25 Jan 2024
Paggiarino Dario A.
Chief Medical Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
36,805
-1%
600
$25.00
$15,000.00
SELL
24 Jan 2024
Jones David Scott
SVP & Chief Commercial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
38,262
-23%
11,900
$25.01
$297,621.34
SELL
23 Jan 2024
Lurker Nancy
Executive Vice Chair, Director, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
135,441
-20%
35,000
$24.98
$874,199.60
SELL
23 Jan 2024
Paggiarino Dario A.
Chief Medical Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
42,156
-27%
16,386
$25.01
$409,790.22
SELL
22 Jan 2024
Jones David Scott
SVP & Chief Commercial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
38,462
-47%
35,066
$22.68
$795,191.40
SELL
11 Jan 2024
Liu Ye
Director
EyePoint Pharmaceuticals, Inc.
(EYPT)
100,221
-95%
1,910,500
$19.45
$37,159,228.00
SELL
11 Jan 2024
Ocumension Therapeutics
Director
EyePoint Pharmaceuticals, Inc.
(EYEP)
100,221
-95%
1,910,500
$19.45
$37,159,228.00
BUY
9 Jan 2024
Cormorant Asset Management, LP
10% Owner
EyePoint Pharmaceuticals, Inc.
(EYPT)
6,893,235
+14%
855,000
$19.94
$17,051,100.00
SELL
8 Jan 2024
Paggiarino Dario A.
Chief Medical Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
36,505
-38%
22,913
$21.13
$484,124.20
SELL
13 Dec 2023
Paggiarino Dario A.
Chief Medical Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
25,707
-5%
1,458
$20.00
$29,160.00
SELL
1 Sep 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 3
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,490,921
-0%
20,000
$9.90
$197,982.00
SELL
1 Sep 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 3
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,490,921
-0%
20,000
$9.90
$197,982.00
SELL
30 Aug 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 6
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,517,938
-3%
139,471
$10.54
$1,470,208.40
SELL
28 Aug 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 4
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,650,957
-3%
148,712
$11.14
$1,656,878.00
SELL
24 Aug 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 2
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,853,760
-5%
223,936
$13.25
$2,967,571.80
SELL
24 Aug 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 6
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,810,835
-5%
223,936
$11.11
$2,487,482.00
SELL
22 Aug 2023
EW Healthcare Partners, L.P.
10% Owner, See footnotes 1 and 2
EyePoint Pharmaceuticals, Inc.
(EYPT)
4,023,040
-4%
167,881
$13.49
$2,264,748.50
SELL
30 May 2023
Liu Ye
Director
EyePoint Pharmaceuticals, Inc.
(EYPT)
3,010,721
-0%
1
$6.00
$6.00
BUY
14 Mar 2022
Pine Michael Craig
Chief Corp Dev.&Strat. Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
1,000
+100%
1,000
$12.21
$12,210.00
SELL
15 Nov 2021
Lurker Nancy
President & CEO, Director, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
103,546
-8%
10,000
$20.15
$201,480.00
BUY
4 Sep 2020
Elston George
Chief Financial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
40,000
+2%
1,000
$4.80
$4,800.00
BUY
24 Aug 2020
Elston George
Chief Financial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
30,000
+3%
1,000
$6.11
$6,112.00
BUY
12 Mar 2020
Elston George
Chief Financial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
20,000
+5%
1,000
$9.60
$9,600.00
BUY
10 Mar 2020
Lurker Nancy
President & CEO, Director, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
574,800
+1%
9,800
$10.62
$104,026.99
BUY
14 Nov 2019
Elston George
Chief Financial Officer, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
10,000
+11%
1,000
$14.29
$14,290.00
BUY
13 May 2019
Landis John B.
Director
EyePoint Pharmaceuticals, Inc.
(EYPT)
40,000
+11%
4,000
$17.40
$69,600.00
BUY
1 Apr 2019
Duker Jay S.
Director
EyePoint Pharmaceuticals, Inc.
(EYPT)
17,500
+2%
500
$18.90
$9,450.00
BUY
29 Mar 2019
Lurker Nancy
President & CEO, Director, Officer
EyePoint Pharmaceuticals, Inc.
(EYPT)
240,200
+1%
2,850
$17.63
$50,245.50
BUY
29 Mar 2019
Godshall Douglas Evan
Director
EyePoint Pharmaceuticals, Inc.
(EYPT)
29,500
+6%
1,700
$17.52
$29,784.00
BUY
25 Jun 2018
EW Healthcare Partners, L.P.
10% Owner
EyePoint Pharmaceuticals, Inc.
(EYPT)
25,470,390
+7%
1,686,406.6
$12.65
$21,333,042.00
BUY
28 Mar 2018
EW Healthcare Partners, L.P.
10% Owner
EyePoint Pharmaceuticals, Inc.
(PSDV)
8,606,324
+11%
860,632.44
$11.00
$9,466,956.00
BUY
14 Jun 2017
Lurker Nancy
President and CEO, Director, Officer
pSivida Corp.
(PSDV)
56,700
+11%
5,670
$17.63
$99,962.10
SELL
4 Jan 2016
Ross Leonard S
Vice President, Finance, Officer
pSivida Corp.
(PSDV)
0
-100%
500
$47.00
$23,500.00
Home